Moderna, a pharmaceutical company, petitioned the FDA on Thursday to approve a fourth dosage of its COVID-19 vaccination as a booster dose for all adults.
The request is more comprehensive than Pfizer’s appeal to the FDA earlier this week for approval of a booster injection for all seniors.
The business claimed in a news statement that it requested permission for all adults “to allow flexibility” to the CDC and medical practitioners in determining the “appropriate use” of a second booster dose of the mRNA vaccine, “particularly for individuals at increased risk of COVID-19 owing to age or comorbidities.”
Officials in the United States have been building the basis for the delivery of extra booster doses to bolster the vaccinations’ protection against COVID-19-related severe sickness and death. The White House has been warning Congress that more funds for the federal government is needed “urgently” in order to get more doses of the COVID-19 vaccinations, either for further booster injections or variant-specific immunizations.
Officials in the United States presently prescribe two doses of the Moderna vaccine as a primary series, followed by a booster dose many months later.
Moderna’s request for a second dosage was based on “recently released data collected in the United States and Israel following the launch of Omicron,” according to the company.
Pfizer and its partner BioNTech urged US authorities on Tuesday to approve an additional booster dosage of their COVID-19 vaccination for seniors, citing data from Israel as evidence.
